JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Activity Details

542 * ! Wed, 8/1/2012, 2:00 PM - 3:50 PM CC-Room 22
Progress in Pre-Clinical Safety Biomarker Qualification in the Predictive Safety Testing Consortium (PSTC): An FDA Critical Path Initiative — Invited Papers
Biopharmaceutical Section
Organizer(s): Xiaoyu Jiang, Novartis Institutes for BioMedical Research
Chair(s): Xiaoyu Jiang, Novartis Institutes for BioMedical Research
2:05 PM Observational Study to Determine Reference Ranges for Novel Renal Biomarkers in Healthy Volunteers Jaromir Mikl, Boehringer Ingelheim Pharmaceuticals, Inc.
2:25 PM Statistical Methods for Biomarker Performance Evaluation David Raunig, ICON Medical Imaging
3:05 PM Kidney Toxicity Biomarker Qualification: A Journey Along the Critical Path Dan Holder, Merck Research Laboratories
3:25 PM Lessons Learned from the Carcinogenicity Working Group: From Biomarker Discovery to Predictive Modeling Alex Adai, Asuragen, Inc.
3:35 PM Discussant: Sue-Jane Wang, FDA
3:45 PM Floor Discussion

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.